Infusion of bcr/abl peptide-reactive donor T cells to achieve molecular remission of chronic myeloid leukemia after CD34+ selected allogeneic hematopoietic cell transplantation

Leukemia. 2006 Nov;20(11):2055-7. doi: 10.1038/sj.leu.2404383. Epub 2006 Aug 31.

Authors

M Bornhauser, C Thiede, J Babatz, J Schetelig, T Illmer, A Kiani, U Platzbecker, W Herr, E-P Rieber, G Ehninger, M Schmitz

PMID: 16990776
DOI: 10.1038/sj.leu.2404383

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adoptive Transfer / methods*
Adult
Antigens, CD34 / metabolism
Dendritic Cells / metabolism
Fusion Proteins, bcr-abl*
Hematopoietic Stem Cell Transplantation*
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / immunology
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
Male
Peptide Fragments / metabolism
Peptide Fragments / therapeutic use
Remission Induction
T-Lymphocytes / metabolism
T-Lymphocytes / transplantation*
Transplantation, Homologous

Substances

Antigens, CD34
Peptide Fragments
Fusion Proteins, bcr-abl